These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 19172648
1. Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Bodini B, Khaleeli Z, Cercignani M, Miller DH, Thompson AJ, Ciccarelli O. Hum Brain Mapp; 2009 Sep; 30(9):2852-61. PubMed ID: 19172648 [Abstract] [Full Text] [Related]
2. A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis. Ceccarelli A, Rocca MA, Valsasina P, Rodegher M, Pagani E, Falini A, Comi G, Filippi M. Hum Brain Mapp; 2009 Sep; 30(9):3009-19. PubMed ID: 19172642 [Abstract] [Full Text] [Related]
3. MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis. Tortorella P, Rocca MA, Mezzapesa DM, Ghezzi A, Lamantia L, Comi G, Filippi M. J Neurol; 2006 Jul; 253(7):903-7. PubMed ID: 16511645 [Abstract] [Full Text] [Related]
4. Regional but not global brain damage contributes to fatigue in multiple sclerosis. Rocca MA, Parisi L, Pagani E, Copetti M, Rodegher M, Colombo B, Comi G, Falini A, Filippi M. Radiology; 2014 Nov; 273(2):511-20. PubMed ID: 24927473 [Abstract] [Full Text] [Related]
8. Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis. Eshaghi A, Bodini B, Ridgway GR, García-Lorenzo D, Tozer DJ, Sahraian MA, Thompson AJ, Ciccarelli O. Neuroimage; 2014 Feb 01; 86():257-64. PubMed ID: 24099844 [Abstract] [Full Text] [Related]
9. Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. Raz E, Cercignani M, Sbardella E, Totaro P, Pozzilli C, Bozzali M, Pantano P. Radiology; 2010 Nov 01; 257(2):448-54. PubMed ID: 20858849 [Abstract] [Full Text] [Related]
10. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Sastre-Garriga J, Ingle GT, Chard DT, Ramió-Torrentà L, McLean MA, Miller DH, Thompson AJ. Arch Neurol; 2005 Apr 01; 62(4):569-73. PubMed ID: 15824254 [Abstract] [Full Text] [Related]
11. Gray matter atrophy in multiple sclerosis: a longitudinal study. Fisher E, Lee JC, Nakamura K, Rudick RA. Ann Neurol; 2008 Sep 01; 64(3):255-65. PubMed ID: 18661561 [Abstract] [Full Text] [Related]
12. Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. Khaleeli Z, Sastre-Garriga J, Ciccarelli O, Miller DH, Thompson AJ. J Neurol Neurosurg Psychiatry; 2007 Oct 01; 78(10):1076-82. PubMed ID: 17287235 [Abstract] [Full Text] [Related]
13. Gray matter atrophy is related to long-term disability in multiple sclerosis. Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH. Ann Neurol; 2008 Sep 01; 64(3):247-54. PubMed ID: 18570297 [Abstract] [Full Text] [Related]
16. Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis. Fisniku LK, Altmann DR, Cercignani M, Tozer DJ, Chard DT, Jackson JS, Miszkiel KA, Schmierer K, Thompson AJ, Miller DH. Mult Scler; 2009 Jun 01; 15(6):668-77. PubMed ID: 19435751 [Abstract] [Full Text] [Related]
17. Combined analyses of gray matter voxel-based morphometry and white matter tract-based spatial statistics in pediatric bipolar mania. Gao W, Jiao Q, Qi R, Zhong Y, Lu D, Xiao Q, Lu S, Xu C, Zhang Y, Liu X, Yang F, Lu G, Su L. J Affect Disord; 2013 Aug 15; 150(1):70-6. PubMed ID: 23477846 [Abstract] [Full Text] [Related]
18. Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis. Tur C, Penny S, Khaleeli Z, Altmann DR, Cipolotti L, Ron M, Thompson AJ, Ciccarelli O. Mult Scler; 2011 Nov 15; 17(11):1324-32. PubMed ID: 21803874 [Abstract] [Full Text] [Related]
19. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study. Zivadinov R, Bergsland N, Hagemeier J, Tavazzi E, Ramasamy DP, Durfee J, Cherneva M, Carl E, Carl J, Kolb C, Hojnacki D, Weinstock-Guttman B. J Neurol Sci; 2018 Apr 15; 387():152-156. PubMed ID: 29571854 [Abstract] [Full Text] [Related]
20. A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS. Bodini B, Cercignani M, Toosy A, De Stefano N, Miller DH, Thompson AJ, Ciccarelli O. Hum Brain Mapp; 2014 Feb 15; 35(2):723-33. PubMed ID: 23616276 [Abstract] [Full Text] [Related] Page: [Next] [New Search]